Breaking News Instant updates and real-time market news.

CDNA

CareDx

$3.00

-0.15 (-4.76%)

05:10
11/22/16
11/22
05:10
11/22/16
05:10

CareDx receives notice from CMS that CLFS for AlloMap to remain at $2,821

CareDx announced that the Centers for Medicare & Medicaid Services, or CMS, issued final changes to the CY 2017 Medicare Clinical Laboratory Fee Schedule, or CLFS. These fee changes included AlloMap, which reverted from a proposed rate of $1,920 back to the current reimbursement rate of $2,821. CMS mentioned that changes were based on public input on the preliminary determinations and final 2016 gapfill files issued on September 30, 2016.

  • 29

    Nov

CDNA CareDx
$3.00

-0.15 (-4.76%)

06/13/16
LEER
06/13/16
NO CHANGE
LEER
CMS price proposals for diagnostic tests a negative for most, says Leerink
Leerink analyst Dan Leonard expects several diagnostics stocks to underperform following proposed price cuts or low initial reimbursement rates by the Centers for Medicare and Medicaid Services, or CMS, for diagnostic tests. If finalized, the preliminary pricing would negatively impact CareDx (CDNA), Veracyte (VCYT), and InVitae (NVTA), the analyst tells investors in a research note, adding that he also sees an indirect negative read-through for Illumina (ILMN).
06/13/16
CANT
06/13/16
NO CHANGE
Target $13
CANT
Buy
Cantor sees 'flawed methodology' with new CMS rates
Cantor Fitzgerald analyst Bryan Brokmeier says shares of Veracyte (VCYT) may be under pressure this morning following Friday's release of a proposed gapfill Medicare reimbursement rate reduction on the company's Afirma GEC. Along with the 30% reduction on Afirma's GEC, the release from the Centers for Medicare and Medicaid Services resets rates on 15 other molecular diagnostic tests, including reductions in CareDx's (CNDA) AlloMap, which is down 74%, Genomic Health's (GHDX) Oncotype Dx Colon, which is down 73%, and Rosetta Genomics' (ROSG) Cancer Origin Test, which is down 57%, Brokmeier tells investors in a research note. The analyst, however, believes the preliminary proposed gapfill rate is based on a "flawed methodology" because it is the median proposed rate submitted by all Medicare Administrative Contractors, including those that have little or no experience administering claims on these tests, Brokmeier contends. He points out that Medicare represents approximately 20% of Afirma GEC test volume for Veracyte. Based on 2015 volume, the 30% Medicare rate reduction for Afirma would reduce total revenues by $3.7M or 7.5%, he adds. The analyst keeps a Buy rating on Veracyte with a $13 price target.
06/20/16
PIPR
06/20/16
NO CHANGE
PIPR
Final PAMA rule better than expected, says Piper Jaffray
Piper Jaffray analyst William Quirk says the final Protecting Access to Medicare Act published Friday by Centers for Medicare & Medicaid Services is better than expected. PAMA is delayed until 2018 from 2017 as expected, Quirk tells investors in a research note. Hospital labs will be required to submit private payer rates to CMS, a positive relative to prior expectations, the analyst notes. He views the decision as beneficial for Quest Diagnostics (DGX) and LabCorp (LH). Further, CMS will require labs to submit only in-network rates and out-of-network "final" rates, which is a positive for specialty labs who have in-network rates at or above Medicare including CareDx (CDNA), Genomic Health (GHDX), Myriad Genetics (MYGN), Oxford Immunotec (OXFD) and Veracyte (VCYT), Quirk writes.
07/07/16
PIPR
07/07/16
NO CHANGE
PIPR
New FDA recommendation positive for lab companies, says Piper Jaffray
Piper Jaffray analyst William Quirk says that the FDA has issued draft guidance to streamline its approval process for next-generation sequencing, or NGS, germline tests, which could be a substitute for a Premarket Notification or 510k. The analyst believes streamlined regulatory approaches for NGS tests are a positive for labs with NGS laboratory-developed tests such as CareDx (CDNA), Quest Diagnostics (DGX), Genomic Health (GHDX), LabCorp (LH), Myriad Genetics (MYGN), Natera (NTRA), Oxford Immunotec (OXFD), Sequenom (SQNM), Trovagene (TROV), and Veracyte (VCYT).

TODAY'S FREE FLY STORIES

SWKS

Skyworks

$74.82

1.48 (2.02%)

11:00
12/06/16
12/06
11:00
12/06/16
11:00
Options
Nice timing of an early sweep in Weekly options on Skyworks Solutions »

Nice timing of an early…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 14

    Dec

PAVM

PAVmed

10:59
12/06/16
12/06
10:59
12/06/16
10:59
Conference/Events
PAVmed to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

HAR

Harman

$109.79

0.125 (0.11%)

10:57
12/06/16
12/06
10:57
12/06/16
10:57
Hot Stocks
Breaking Hot Stocks news story on Harman »

JP Morgan lowers passive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 10

    Jan

BWA

BorgWarner

$38.48

0.99 (2.64%)

10:56
12/06/16
12/06
10:56
12/06/16
10:56
Technical Analysis
BorgWarner moves higher, potential bullish pattern »

The shares are up over…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jan

EC

Ecopetrol

$8.74

0.14 (1.63%)

10:56
12/06/16
12/06
10:56
12/06/16
10:56
Recommendations
Ecopetrol analyst commentary  »

Ecopetrol added to the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$762.52

12.02 (1.60%)

, GOOGL

Alphabet Class A

$778.22

13.76 (1.80%)

10:55
12/06/16
12/06
10:55
12/06/16
10:55
Hot Stocks
Google Wifi now available for purchase »

According to an email by…

GOOG

Alphabet

$762.52

12.02 (1.60%)

GOOGL

Alphabet Class A

$778.22

13.76 (1.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Jan

VLKAY

Volkswagen

$27.98

0.8 (2.94%)

10:55
12/06/16
12/06
10:55
12/06/16
10:55
Conference/Events
House Energy & Commerce Committee to hold a hearing »

The Oversight &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 05

    Jan

  • 10

    Jan

BOBE

Bob Evans

$46.77

1.05 (2.30%)

, JPM

JPMorgan

$82.99

-0.27 (-0.32%)

10:51
12/06/16
12/06
10:51
12/06/16
10:51
Hot Stocks
Bob Evans holder Sandell 'encouraged' by retention of financial advisor »

Sandell Asset Management,…

BOBE

Bob Evans

$46.77

1.05 (2.30%)

JPM

JPMorgan

$82.99

-0.27 (-0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 06

    Dec

  • 06

    Dec

  • 09

    Jan

  • 13

    Jan

  • 28

    Feb

  • 14

    Jul

  • 12

    Oct

ETE

Energy Transfer Equity

$16.24

0.17 (1.06%)

10:50
12/06/16
12/06
10:50
12/06/16
10:50
Options
Notable call spreads in Energy Transfer Equity »

Notable call spreads in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSFT

Microsoft

$60.22

0.97 (1.64%)

, LNKD

LinkedIn

$195.41

0.16 (0.08%)

10:49
12/06/16
12/06
10:49
12/06/16
10:49
Hot Stocks
European Commission approves acquisition of LinkedIn by Microsoft »

The European Commission…

MSFT

Microsoft

$60.22

0.97 (1.64%)

LNKD

LinkedIn

$195.41

0.16 (0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BW

Babcock & Wilcox

$16.02

0.03 (0.19%)

10:47
12/06/16
12/06
10:47
12/06/16
10:47
Conference/Events
Babcock & Wilcox management to meet with William Blair »

Group luncheon with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

RIG

Transocean

$14.13

0.15 (1.07%)

10:47
12/06/16
12/06
10:47
12/06/16
10:47
Hot Stocks
Transocean announces approval of merger with Transocean Partners »

Transocean announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WERN

Werner

$27.90

0.2 (0.72%)

10:46
12/06/16
12/06
10:46
12/06/16
10:46
Conference/Events
Werner management to meet with Stephens »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

SNN

Smith & Nephew

$28.77

0.27 (0.95%)

10:46
12/06/16
12/06
10:46
12/06/16
10:46
Conference/Events
Smith & Nephew management to meet with Jefferies »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

RP

RealPage

$28.80

0.25 (0.88%)

10:45
12/06/16
12/06
10:45
12/06/16
10:45
Conference/Events
RealPage management to meet with JMP Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 13

    Dec

10:45
12/06/16
12/06
10:45
12/06/16
10:45
General news
The U.S. factory goods data slightly underperformed »

The U.S. factory goods…

BAC

Bank of America

$21.81

-0.03 (-0.14%)

10:44
12/06/16
12/06
10:44
12/06/16
10:44
Hot Stocks
Bank of America CEO: $53B cost-cutting target reflects 'environment we're in' »

Says "tremendous…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 13

    Jan

RP

RealPage

$28.80

0.25 (0.88%)

10:44
12/06/16
12/06
10:44
12/06/16
10:44
Conference/Events
RealPage management to meet with Stephens »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 13

    Dec

MMI

Marcus & Millichap

$27.72

-0.1 (-0.36%)

10:44
12/06/16
12/06
10:44
12/06/16
10:44
Conference/Events
Marcus & Millichap management to meet with JMP Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 07

    Dec

IT

Gartner

$101.15

0.46 (0.46%)

10:43
12/06/16
12/06
10:43
12/06/16
10:43
Conference/Events
Gartner management to meet with William Blair »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

HIBB

Hibbett Sports

$42.55

2.1 (5.19%)

10:42
12/06/16
12/06
10:42
12/06/16
10:42
Conference/Events
Hibbett Sports management to meet with Canaccord »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 07

    Dec

ISRG

Intuitive Surgical

$636.95

0.31 (0.05%)

10:42
12/06/16
12/06
10:42
12/06/16
10:42
Technical Analysis
Intuitive Surgical falls, levels to watch »

The stock was last at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 07

    Dec

  • 07

    Dec

AOSL

Alpha & Omega

$20.51

0.43 (2.14%)

10:40
12/06/16
12/06
10:40
12/06/16
10:40
Conference/Events
Alpha & Omega management to meet with Drexel Hamilton »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

SBUX

Starbucks

$57.50

0.29 (0.51%)

10:40
12/06/16
12/06
10:40
12/06/16
10:40
Options
Option action heats up in Starbuck's weeklys »

Option action heats up in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

AIRM

Air Methods

$32.70

0.15 (0.46%)

10:39
12/06/16
12/06
10:39
12/06/16
10:39
Conference/Events
Air Methods management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.